Paper Details

  1. Home
  2. Paper Details

The effects of apixaban on hospitalizations in patients with different types of atrial fibrillation: insights from the AVERROES trial.

Author: ConnollyStuart J, EikelboomJohn, FranzosiMaria Grazia, HohnloserStefan H, ShestakovskaOlga, TanRu San, YusufSalim, ZhuJun

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Apixaban therapy was associated with a lower risk of cardiovascular hospitalization in patients with atrial fibrillation (AF), particularly for stroke and other cardiovascular causes.
Paper Details　
Original Abstract of the Article :
AIMS: The aim of this study was to evaluate the effects of apixaban, a novel oral factor Xa inhibitor, on the need for cardiovascular hospitalization. METHODS AND RESULTS: Our analysis is based on data from AVERROES, a randomized double-blind trial testing the efficacy and safety of apixaban agains...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1093/eurheartj/eht292

データ提供：米国国立医学図書館（NLM）

Atrial Fibrillation: A Desert of Rhythmic Disruptions

Atrial fibrillation (AF), a heart rhythm disorder, is like a desert where the rhythmic beating of the heart becomes chaotic and unpredictable. This research explores the effects of apixaban, a novel blood thinner, on hospitalization rates in patients with AF. The authors carefully analyze the data from a large clinical trial, seeking to understand the potential benefits of apixaban in managing this condition.

Apixaban: A Potential Oasis in the Desert

The study found that apixaban significantly reduced the risk of hospitalization in patients with AF, especially for stroke and other cardiovascular events. This is like discovering a hidden oasis in the heart of a chaotic desert, offering a much-needed respite from the challenges of AF. The authors suggest that apixaban may offer a more effective and safe alternative to aspirin for preventing stroke in patients with AF.

Navigating the Sands of Treatment

This research offers a promising new direction for managing AF, suggesting that apixaban might be a valuable tool for reducing hospitalizations and improving patient outcomes. However, like a desert explorer, we must continue to investigate this promising discovery, further exploring its potential and ensuring its safety and efficacy in human patients.

Dr. Camel's Conclusion

This study presents a valuable insight into the potential of apixaban for managing atrial fibrillation. Just as a desert is a complex and ever-changing landscape, so too is the realm of heart rhythm disorders. This research suggests that apixaban might offer a more effective and personalized approach to managing these challenges.

Date :
  1. Date Completed 2014-04-09
  2. Date Revised 2013-09-16
Further Info :

Pubmed ID

23892201

DOI: Digital Object Identifier

10.1093/eurheartj/eht292

Related Literature

Article Analysis
・Effects of apixaban・Effects of acalabrutinib
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.